子宮内膜癌分子診断の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2517)
◆英語タイトル:Global Molecular Diagnosis of Endometrial Carcinoma Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2517
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、子宮内膜癌分子診断の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(PCR、FISH、DNAシーケンシング、ジーンチップ)、用途別市場規模(臨床診断、薬物スクリーニング、研究)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・子宮内膜癌分子診断の市場動向
・企業の競争状況、市場シェア
・子宮内膜癌分子診断の種類別市場規模(PCR、FISH、DNAシーケンシング、ジーンチップ)
・子宮内膜癌分子診断の用途別市場規模(臨床診断、薬物スクリーニング、研究)
・子宮内膜癌分子診断の北米市場規模2016-2027(アメリカ、カナダ)
・子宮内膜癌分子診断の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・子宮内膜癌分子診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・子宮内膜癌分子診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・子宮内膜癌分子診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Inmedi、United Gene Group、Topgen、Gene+、Sanvalley、BGHDL、Homey Health)
・結論
【レポートの概要】

A method for diagnosing endometrial carcinoma

Market Analysis and Insights: Global Molecular Diagnosis of Endometrial Carcinoma Market
The global Molecular Diagnosis of Endometrial Carcinoma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnosis of Endometrial Carcinoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnosis of Endometrial Carcinoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnosis of Endometrial Carcinoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnosis of Endometrial Carcinoma market.

Global Molecular Diagnosis of Endometrial Carcinoma Scope and Market Size
Molecular Diagnosis of Endometrial Carcinoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnosis of Endometrial Carcinoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Inmedi
United Gene Group
Topgen
Gene+
Sanvalley
BGHDL
Homey Health

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Perspective (2016-2027)
2.2 Molecular Diagnosis of Endometrial Carcinoma Growth Trends by Regions
2.2.1 Molecular Diagnosis of Endometrial Carcinoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnosis of Endometrial Carcinoma Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnosis of Endometrial Carcinoma Industry Dynamic
2.3.1 Molecular Diagnosis of Endometrial Carcinoma Market Trends
2.3.2 Molecular Diagnosis of Endometrial Carcinoma Market Drivers
2.3.3 Molecular Diagnosis of Endometrial Carcinoma Market Challenges
2.3.4 Molecular Diagnosis of Endometrial Carcinoma Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis of Endometrial Carcinoma Players by Revenue
3.1.1 Global Top Molecular Diagnosis of Endometrial Carcinoma Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis of Endometrial Carcinoma Revenue
3.4 Global Molecular Diagnosis of Endometrial Carcinoma Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Endometrial Carcinoma Revenue in 2020
3.5 Molecular Diagnosis of Endometrial Carcinoma Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis of Endometrial Carcinoma Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis of Endometrial Carcinoma Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnosis of Endometrial Carcinoma Breakdown Data by Type
4.1 Global Molecular Diagnosis of Endometrial Carcinoma Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Type (2022-2027)

5 Molecular Diagnosis of Endometrial Carcinoma Breakdown Data by Application
5.1 Global Molecular Diagnosis of Endometrial Carcinoma Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
6.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
6.2.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
6.3 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
6.3.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
6.4 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
6.4.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
7.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
7.2.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
7.3.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
7.4.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
9.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
9.2.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
9.3.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
9.4.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Inmedi
11.1.1 Inmedi Company Details
11.1.2 Inmedi Business Overview
11.1.3 Inmedi Molecular Diagnosis of Endometrial Carcinoma Introduction
11.1.4 Inmedi Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.1.5 Inmedi Recent Development
11.2 United Gene Group
11.2.1 United Gene Group Company Details
11.2.2 United Gene Group Business Overview
11.2.3 United Gene Group Molecular Diagnosis of Endometrial Carcinoma Introduction
11.2.4 United Gene Group Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.2.5 United Gene Group Recent Development
11.3 Topgen
11.3.1 Topgen Company Details
11.3.2 Topgen Business Overview
11.3.3 Topgen Molecular Diagnosis of Endometrial Carcinoma Introduction
11.3.4 Topgen Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.3.5 Topgen Recent Development
11.4 Gene+
11.4.1 Gene+ Company Details
11.4.2 Gene+ Business Overview
11.4.3 Gene+ Molecular Diagnosis of Endometrial Carcinoma Introduction
11.4.4 Gene+ Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.4.5 Gene+ Recent Development
11.5 Sanvalley
11.5.1 Sanvalley Company Details
11.5.2 Sanvalley Business Overview
11.5.3 Sanvalley Molecular Diagnosis of Endometrial Carcinoma Introduction
11.5.4 Sanvalley Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.5.5 Sanvalley Recent Development
11.6 BGHDL
11.6.1 BGHDL Company Details
11.6.2 BGHDL Business Overview
11.6.3 BGHDL Molecular Diagnosis of Endometrial Carcinoma Introduction
11.6.4 BGHDL Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.6.5 BGHDL Recent Development
11.7 Homey Health
11.7.1 Homey Health Company Details
11.7.2 Homey Health Business Overview
11.7.3 Homey Health Molecular Diagnosis of Endometrial Carcinoma Introduction
11.7.4 Homey Health Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.7.5 Homey Health Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 子宮内膜癌分子診断の世界市場規模・現状・予測2021年-2027年(Global Molecular Diagnosis of Endometrial Carcinoma Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。